Updated: October 4, 2019

Listed here are opportunities available to CBC researchers through CBC-supported efforts as well as through CBC-independent initiatives.


CBC-Supported Opportunities

Chicago Synthetic Antibody Pipeline (CSAP)

Due to a CBC Lever Award, CBC researchers have special access to this powerful technology:


Other Opportunities

Posted: October 4, 2019
Keystone Symposium — The Brain Therapeutics: Disruptive Technologies and Opportunities
Date: February 16—19, 2020
Location: Eldorado Hotel & Spa, Santa Fe, New Mexico

Attention students and post-doctoral fellows: the KS scholarship deadline is fast approaching (Oct. 15!). Not only are KS Scholarships prestigious, but they also provide up-and-coming scientists with invaluable networking and career-development opportunities to advance their research, and careers. Awardees will present their work alongside field leaders, and be introduced to scientific and technological frontiers to inspire new, fruitful research directions and collaborations.
▸ Learn more

Posted: September 19, 2019
Tau2020 Global Conference
Date: February 12-13, 2020
Location: Marriott Marquis Washington, D.C.

In partnership with CurePSP and the Alzheimer’s Association, the Rainwater Foundation is a proud organizing sponsor of the Tau2020 Global Conference. The conference is open to anyone with an interest in research about the causes and treatments for tau-related diseases. Representatives from academia, industry, government, and the philanthropic/advocacy sector are encouraged to attend.
▸ Learn more

Posted: September 10, 2019
Funding Opportunity – The Tau Pipeline Enabling Program (T-PEP)

The Tau Pipeline Enabling Program (T-PEP) seeks to accelerate the discovery of potential new therapies for tauopathies. The intent of this program is to enrich the pipeline for therapy development by facilitating the translation of academia derived ideas into practical application. In short, it bridges the gap between innovative but resource-constrained researchers and the larger pharmaceutical companies that are looking for drug candidates to be taken into human trials.

The overarching goal of T-PEP is to promote the advanced study of a wide range of novel targets, agents and/or therapeutic strategies that will accelerate the development of disease modifying interventions for tauopathies.

T-PEP is open to researchers at academic institutions as well as small companies. There is no strict cut-off for company size, but preference will be given to companies with 50 or fewer employees.The maximum grant amount is $750,000. Non-profit academic institutions are allowed up to 10% indirect costs; no indirect costs are allowable for for-profit companies. The maximum project duration is 2 years, and there is no minimum time frame. As co-sponsors of the grant program, the Alzheimer’s Association and the Tau Consortium will jointly monitor progress toward project milestones; continued disbursement of funds may be made contingent on demonstrated progress toward key milestones.

LOI Deadline: September 12, 2019, 5:00 PM ET
LOI is now open: https://proposalcentral.com/GrantOpportunities.asp
▸ Learn more

Posted: September 10, 2019
Lakeside Discovery and West Loop Innovations announce Fall 2019 RFP

The timeline for the submission cycle is identical for both Lakeside Discovery and West Loop Innovations. RFP opened September 3, 2019; LOIs submissions deadline October 9, 2019.
▸ Learn more

Posted: August 19, 2019
Job Opportunity: ClostraBio is seeking talented people!

ClostraBio is looking for a Scientific Operations Manager to drive the ongoing development of ClostraBio’s microbiome-modulating technologies. ClostraBio is a preclinical stage company creating new medicines to prevent and treat food allergy. These medicines work by altering the microbiome – the trillions of bacteria, viruses, fungi, and related compounds – that live in the human gut. Founded in 2016 based on groundbreaking work from the University of Chicago, the company has raised $4.6M to date and now supports 4 employees through a sponsored research agreement with the University of Chicago.

▸ Learn more

Posted: August 8, 2018
New, Updated and Expanded Services provided by the University of Chicago Genomics Facility

The University of Chicago Genomics Facility has:

Posted: August 1, 2018
New Opportunities for the CBC Community

Northwestern’s NSF-Simons Center for Quantitative Biology has a few opportunities for researchers in quantitative biology.

Posted: October 27, 2015
University of Chicago Graham School Launches Master of Science Degree in Biomedical Informatics

Biomedical informatics, one of the world’s fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies. The University brings together its esteemed faculty and programs in genomic research, translational medicine, and computation within the new Master of Science Degree in Biomedical Informatics (MScBMI).

▸ Press Release, October 27, 2015 (PDF)
▸ Program website

Posted: March 30, 2015
Globus Genomics for Core Labs

Globus Genomics is an end-to-end data management and large scale analysis service that addresses the challenges that researchers face when dealing with NGS analysis on a large scale. It combines state-of-the-art algorithms with sophisticated data management tools, a powerful graphical workflow environment, and a cloud-based elastic computational infrastructure. Globus Genomics is software-as-a-service, delivered as a monthly subscription with the appropriate level of resources to meet your specific needs. Globus Genomics is being used by over a dozen informatics cores, research groups at various universities. For a limited period, we are offering Globus Genomics for free for a month to qualified researchers in the CBC. Please contact Ravi Madduri or Paul Dave for more information.

▸ Program website
▸ Download flyer (PDF)